Filing Details

Accession Number:
0001140361-14-009240
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-24 15:56:31
Reporting Period:
2014-02-20
Filing Date:
2014-02-24
Accepted Time:
2014-02-24 15:56:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1094176 Anne M Szostak One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-20 2,000 $126.71 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $126.65 to $126.83, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.